Delek Group’s Prothena Corp PRTA Stock Holding History

Delek Group’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-30,000	Closed	-$1.12M	–	292
2017 Q4	$1.12M	Buy	+30,000	New	+$1.53M	0.06%	180

Other funds holding PRTA

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Delek Group's PRTA Position: Q1 2018 in Review

Delek Group sold out of Prothena Corp (PRTA) in Q1 2018, closing a stake of 30,000 shares — an estimated $1.12M sold.

Delek Group first reported a position in PRTA in Q4 2017 and held it in 1 quarter. The position peaked at $1.12M in Q4 2017. 142 funds tracked by Wall St. Rank hold PRTA as of Q1 2018.

Delek Group reported no remaining Prothena Corp position as of Q1 2018 after selling out during the quarter.
Delek Group sold 30,000 Prothena Corp shares in Q1 2018, an estimated $1.12M.
Delek Group first reported a position in Prothena Corp in Q4 2017 and held it in 1 quarter.
Delek Group's Prothena Corp position peaked at $1.12M in Q4 2017.
142 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2018.

Based on Delek Group's 13F filing for Q1 2018, filed 15 May 2018.